Medical Devices Middle East

Middle East Sepsis Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Middle East Sepsis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Biomarker, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Middle East · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $44.8 Mn Placeholder estimate
Estimate 2025 $49.3 Mn 4.6% of the global market
Projected 2034 $117.3 Mn 137.7% Adds $68.0 Mn over 9 forecast years
CAGR 2025–2034 10.1% Faster than 54% of 173 Medical Devices markets here
Key players 5
  • Middle East is 4.61% of the global market.
  • Among regions, the largest is North America at $451.7 Mn.
  • Fastest growing: Africa at 10.3% a year.
  • Middle East ranks 5th of 6 by size among regions.

Market size projection

Middle East

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$68.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Sepsis Diagnostics Market market size by year, Middle East
YearMarket sizeChange that yearSince 2025
2024 (estimate) $44.8 Mn — —
2025 (base) $49.3 Mn +$4.5 Mn —
2026 (forecast) $54.3 Mn +$5.0 Mn +10.1%
2027 (forecast) $59.8 Mn +$5.5 Mn +21.2%
2028 (forecast) $65.8 Mn +$6.0 Mn +33.5%
2029 (forecast) $72.5 Mn +$6.7 Mn +46.9%
2030 (forecast) $79.8 Mn +$7.3 Mn +61.8%
2031 (forecast) $87.9 Mn +$8.1 Mn +78.1%
2032 (forecast) $96.8 Mn +$8.9 Mn +96.1%
2033 (forecast) $106.5 Mn +$9.8 Mn +115.9%
2034 (forecast) $117.3 Mn +$10.8 Mn +137.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Middle East Sepsis Diagnostics Market Analysis at a glance
Market size, 2025$49.3 Mn placeholder estimate
Forecast, 2034$117.3 Mn placeholder estimate
Growth (CAGR), 2025–203410.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, biomarker and end user (see all)
Key playersbioMérieux SA, BD (Becton, Dickinson), Beckman Coulter (Danaher), T2 Biosystems, Prenosis (see all)
Active clinical trials7 in Middle EastSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Middle East Sepsis Diagnostics Market Analysis Executive Summary

Sepsis diagnostics help doctors spot life-threatening sepsis early and find the germ causing it, using blood tests and biomarkers.

Key segments of the sepsis Diagnostics market include technology (Blood Culture, Molecular Diagnostics and Biomarker Assays) and biomarker (Procalcitonin, Lactate and Monocyte Width).

Bar chart: Middle East Sepsis Diagnostics market size, 2024–2034, placeholder estimates. $44.8 Mn in 2024, $49.3 Mn in 2025 and $117.3 Mn in 2034, 10.1% CAGR.
Middle East Sepsis Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Middle East Sepsis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the sepsis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the sepsis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the sepsis Diagnostics market.

Competitive Landscape for Sepsis Diagnostics Market in Middle East

The sepsis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Sepsis Diagnostics Market in Middle East

Sepsis Diagnostics in Middle East: rules, payment and research

In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)⁠[1] and EDE (UAE)⁠[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)⁠[3] and mandatory health insurance (UAE)⁠[4]. ClinicalTrials.gov lists 7 studies on Sepsis Diagnostics that are recruiting, active or about to start in Middle East.⁠[5]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Emirates Drug Establishment. Checked 14 Nov 2026.

[3] Council of Health Insurance. Checked 14 Nov 2026.

[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how sepsis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Sepsis Diagnostics right now, from free public sources.

Clinical trials

7 active trials in UAE, Saudi Arabia, Yemen, Jordan, Lebanon, Qatar, Syria, Palestine and Iraq

Recruiting, about to start, or running now. Counted across the 9 countries we report on in Middle East.

Top trial sponsors (worldwide)

  1. AstraZeneca 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Artcline GmbH 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. ImmunityBio, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Bayer AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. CorMedix Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Sepsis Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Sepsis Diagnostics market in Middle East?
Placeholder estimate: about $49.3 Mn in 2025, rising to about $117.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Sepsis Diagnostics market in Middle East growing?
Placeholder estimate: about 10.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Sepsis Diagnostics market report cover?
The report splits the market by technology (Blood Culture, Molecular Diagnostics, Biomarker Assays, AI Risk Scores), biomarker (Procalcitonin, Lactate, Monocyte Width) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Sepsis Diagnostics market?
Key players include bioMérieux SA, BD (Becton, Dickinson), Beckman Coulter (Danaher), T2 Biosystems and Prenosis.
What is driving the Sepsis Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the sepsis Diagnostics market.
How many clinical trials on Sepsis Diagnostics are running in Middle East?
7 studies are recruiting, active or about to start in Middle East, counted across the 9 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.
How much research is published on Sepsis Diagnostics?
PubMed lists 61 papers on Sepsis Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Middle East

See all

Related on diagnostics and lab testing and infectious diseases

See the topic